Form 8-K - Current report
SEC Accession No. 0001493152-26-044605
Filing Date
2026-09-28
Accepted
2026-09-28 16:50:22
Documents
16
Period of Report
2026-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38320
2 EX-1.1 ex1-1.htm EX-1.1 257334
3 EX-5.1 ex5-1.htm EX-5.1 13136
4 GRAPHIC ex1-1_001.jpg GRAPHIC 43965
5 GRAPHIC ex1-1_002.jpg GRAPHIC 34602
6 GRAPHIC ex1-1_003.jpg GRAPHIC 16154
  Complete submission text file 0001493152-26-044605.txt   670082

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aztr-20260928.xsd EX-101.SCH 3017
8 XBRL LABEL FILE aztr-20260928_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE aztr-20260928_pre.xml EX-101.PRE 22360
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3196
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 261417990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)